Patents Assigned to AstrZeneca AB
  • Combination product comprising melagatran and a factor xa inhibitor
    Publication number: 20030158120
    Abstract: There is provided a combination product comprising: (A) melagatran or a pharmaceutically-acceptable derivative thereof; and (B) a Factor Xa inhibitor or a pharmaceutically-acceptable derivative thereof, wherein each components (A) and (B) is formulated in admixture with a pharmaceutically-acceptable adjuvant, diluent or carrier, as well as the use of such a combination product in the treatment of a condition where anticoagulant therapy is indicated.
    Type: Application
    Filed: December 4, 2002
    Publication date: August 21, 2003
    Applicant: AstrZeneca AB
    Inventor: Christer Mattsson